Literature DB >> 21730049

Gain in transcriptional activity by primate-specific coevolution of melanoma antigen-A11 and its interaction site in androgen receptor.

Qiang Liu1, Shifeng Su, Amanda J Blackwelder, John T Minges, Elizabeth M Wilson.   

Abstract

Male sex development and growth occur in response to high affinity androgen binding to the androgen receptor (AR). In contrast to complete amino acid sequence conservation in the AR DNA and ligand binding domains among mammals, a primate-specific difference in the AR NH(2)-terminal region that regulates the NH(2)- and carboxyl-terminal (N/C) interaction enables direct binding to melanoma antigen-A11 (MAGE-11), an AR coregulator that is also primate-specific. Human, mouse, and rat AR share the same NH(2)-terminal (23)FQNLF(27) sequence that mediates the androgen-dependent N/C interaction. However, the mouse and rat AR FXXLF motif is flanked by Ala(33) that evolved to Val(33) in primates. Human AR Val(33) was required to interact directly with MAGE-11 and for the inhibitory effect of the AR N/C interaction on activation function 2 that was relieved by MAGE-11. The functional importance of MAGE-11 was indicated by decreased human AR regulation of an androgen-dependent endogenous gene using lentivirus short hairpin RNAs and by the greater transcriptional strength of human compared with mouse AR. MAGE-11 increased progesterone and glucocorticoid receptor activity independently of binding an FXXLF motif by interacting with p300 and p160 coactivators. We conclude that the coevolution of the AR NH(2)-terminal sequence and MAGE-11 expression among primates provides increased regulatory control over activation domain dominance. Primate-specific expression of MAGE-11 results in greater steroid receptor transcriptional activity through direct interactions with the human AR FXXLF motif region and indirectly through steroid receptor-associated p300 and p160 coactivators.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21730049      PMCID: PMC3191036          DOI: 10.1074/jbc.M111.244715

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  59 in total

Review 1.  Origin and evolution of spermatogenesis genes on the human sex chromosomes.

Authors:  Margaret L Delbridge; Jennifer A Marshall Graves
Journal:  Soc Reprod Fertil Suppl       Date:  2007

2.  The coactivator TIF2 contains three nuclear receptor-binding motifs and mediates transactivation through CBP binding-dependent and -independent pathways.

Authors:  J J Voegel; M J Heine; M Tini; V Vivat; P Chambon; H Gronemeyer
Journal:  EMBO J       Date:  1998-01-15       Impact factor: 11.598

3.  Transcriptional synergy between melanoma antigen gene protein-A11 (MAGE-11) and p300 in androgen receptor signaling.

Authors:  Emily B Askew; Suxia Bai; Amanda J Blackwelder; Elizabeth M Wilson
Journal:  J Biol Chem       Date:  2010-05-06       Impact factor: 5.157

4.  Evolution of the primate androgen receptor: a structural basis for disease.

Authors:  C S Choong; J A Kemppainen; E M Wilson
Journal:  J Mol Evol       Date:  1998-09       Impact factor: 2.395

5.  FXXLF and WXXLF sequences mediate the NH2-terminal interaction with the ligand binding domain of the androgen receptor.

Authors:  B He; J A Kemppainen; E M Wilson
Journal:  J Biol Chem       Date:  2000-07-28       Impact factor: 5.157

6.  Melanoma antigen-11 inhibits the hypoxia-inducible factor prolyl hydroxylase 2 and activates hypoxic response.

Authors:  Olga Aprelikova; Silvia Pandolfi; Sean Tackett; Mark Ferreira; Konstantin Salnikow; Yvona Ward; John I Risinger; J Carl Barrett; John Niederhuber
Journal:  Cancer Res       Date:  2009-01-15       Impact factor: 12.701

7.  Structural characterization of the native NH2-terminal transactivation domain of the human androgen receptor: a collapsed disordered conformation underlies structural plasticity and protein-induced folding.

Authors:  Derek N Lavery; Iain J McEwan
Journal:  Biochemistry       Date:  2008-02-20       Impact factor: 3.162

8.  An androgen receptor NH2-terminal conserved motif interacts with the COOH terminus of the Hsp70-interacting protein (CHIP).

Authors:  Bin He; Suxia Bai; Andrew T Hnat; Rebecca I Kalman; John T Minges; Cam Patterson; Elizabeth M Wilson
Journal:  J Biol Chem       Date:  2004-04-23       Impact factor: 5.157

9.  The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function.

Authors:  N L Chamberlain; E D Driver; R L Miesfeld
Journal:  Nucleic Acids Res       Date:  1994-08-11       Impact factor: 16.971

10.  Human androgen receptor gene ligand-binding-domain mutations leading to disrupted interaction between the N- and C-terminal domains.

Authors:  J Jääskeläinen; A Deeb; J W Schwabe; N P Mongan; H Martin; I A Hughes
Journal:  J Mol Endocrinol       Date:  2006-04       Impact factor: 5.098

View more
  9 in total

1.  Androgen receptor exon 1 mutation causes androgen insensitivity by creating phosphorylation site and inhibiting melanoma antigen-A11 activation of NH2- and carboxyl-terminal interaction-dependent transactivation.

Authors:  William H Lagarde; Amanda J Blackwelder; John T Minges; Andrew T Hnat; Frank S French; Elizabeth M Wilson
Journal:  J Biol Chem       Date:  2012-02-13       Impact factor: 5.157

2.  Androgen receptor regulation by histone methyltransferase Suppressor of variegation 3-9 homolog 2 and Melanoma antigen-A11.

Authors:  Emily B Askew; Suxia Bai; Amanda B Parris; John T Minges; Elizabeth M Wilson
Journal:  Mol Cell Endocrinol       Date:  2016-12-29       Impact factor: 4.102

3.  Evolution of Melanoma Antigen-A11 (MAGEA11) During Primate Phylogeny.

Authors:  Christopher S Willett; Elizabeth M Wilson
Journal:  J Mol Evol       Date:  2018-03-24       Impact factor: 2.395

4.  Primate-specific melanoma antigen-A11 regulates isoform-specific human progesterone receptor-B transactivation.

Authors:  Shifeng Su; Amanda J Blackwelder; Gail Grossman; John T Minges; Lingwen Yuan; Steven L Young; Elizabeth M Wilson
Journal:  J Biol Chem       Date:  2012-08-13       Impact factor: 5.157

5.  Melanoma associated antigen (MAGE)-A3 promotes cell proliferation and chemotherapeutic drug resistance in gastric cancer.

Authors:  Chen Xie; Vinod Vijay Subhash; Arpita Datta; Natalia Liem; Shi Hui Tan; Mei Shi Yeo; Woei Loon Tan; Vivien Koh; Fui Leng Yan; Foong Ying Wong; Wai Keong Wong; Jimmy So; Iain Beehuat Tan; Nisha Padmanabhan; Celestial T Yap; Patrick Tan; Liang Kee Goh; Wei Peng Yong
Journal:  Cell Oncol (Dordr)       Date:  2016-02-11       Impact factor: 6.730

6.  Proto-oncogene activity of melanoma antigen-A11 (MAGE-A11) regulates retinoblastoma-related p107 and E2F1 proteins.

Authors:  Shifeng Su; John T Minges; Gail Grossman; Amanda J Blackwelder; James L Mohler; Elizabeth M Wilson
Journal:  J Biol Chem       Date:  2013-07-12       Impact factor: 5.157

7.  Post-translational Down-regulation of Melanoma Antigen-A11 (MAGE-A11) by Human p14-ARF Tumor Suppressor.

Authors:  John T Minges; Gail Grossman; Ping Zhang; Tal Kafri; Elizabeth M Wilson
Journal:  J Biol Chem       Date:  2015-09-01       Impact factor: 5.157

8.  Melanoma antigen-A11 regulates substrate-specificity of Skp2-mediated protein degradation.

Authors:  Shifeng Su; Xiaoyu Chen; Jiang Geng; John T Minges; Gail Grossman; Elizabeth M Wilson
Journal:  Mol Cell Endocrinol       Date:  2016-10-06       Impact factor: 4.102

9.  MAGE-A11 is activated through TFCP2/ZEB1 binding sites de-methylation as well as histone modification and facilitates ESCC tumor growth.

Authors:  Shina Liu; Fei Liu; Weina Huang; Lina Gu; Lingjiao Meng; Yingchao Ju; Yunyan Wu; Juan Li; Lihua Liu; Meixiang Sang
Journal:  Oncotarget       Date:  2017-12-05
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.